Dermatologists and patients with psoriatic disease approve of a specialist-led model of care

Approval indicated for those 12 years and older with atopic dermatitis that has not responded to previous treatment

Patients on nemolizumab reported improvements in pruritus visual analog scale, Eczema Area and Severity Index, and quality-of-life indicators

Improved survival associated with cirAEs for patients receiving anti-programmed cell death 1 or anti-programmed cell death ligand 1 therapy

Prevalence of depression increased among adults and children with hidradenitis suppurativa

Pfizer also working to improve its current COVID-19 vaccine 'to address any future variant of potential concern, if needed'

Risk higher for people who were aged 65 years or older, immunosuppressed, or had at least one of six underlying conditions

Combination provides greater benefit than nivolumab alone for progression-free survival in untreated metastatic or unresectable melanoma

Significantly more patients receiving secukinumab versus adalimumab achieved PASI 100 response at week 52

Despite recurrence, most patients with hidradenitis suppurativa are very satisfied with their surgical results

Compared with White inpatients, Black inpatients less likely to receive cefazolin, more likely to receive clindamycin for SSTIs

Full vaccination dose, younger age, female sex, and previously having had COVID-19 linked to greater odds of adverse effects

Worsening reported in eczema area and severity index score, numerical rating scale worst itch, and dermatology life quality index

More than a dozen research groups have been observing the omicron variant in lab settings using animals this past month

Baseline ultrasonography more sensitive for detecting lymph node metastases than clinical examination alone

Significantly greater response rate seen in static Physician Global Assessment at week 16 for apremilast versus placebo

Higher intake of dietary fiber linked to longer progression-free survival in melanoma patients on immune checkpoint blockade

In phase 2 trial, spesolimab cleared more lesions than placebo, but it was associated with infections, systemic drug reactions

Conventional neural networks have the potential to automatically perform image-based Psoriasis Area and Severity Index scoring

Protective effect of BoNT found for different indications, including in cosmetic use/facial muscles, migraine/facial and head muscles

Red cell distribution width to hemoglobin ratio shows similar predictive ability to SCORTEN; better discrimination with composite

Patients on TNFi or IL-17i have lower odds of achieving treatment outcomes with comorbid obesity and history of diabetes

Panel of serum protein biomarkers identified and evaluated for potential use in diagnostic testing for early-onset psoriatic arthritis